Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serum albumin measurement
|
3282 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 3 | 2008 | 2013 | ||||||
Triglycerides measurement
|
1418 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.800 | 1.000 | 3 | 2010 | 2019 | ||||||
Eosinophil count procedure
|
1144 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||||
High density lipoprotein measurement
|
1440 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.800 | 1.000 | 2 | 2010 | 2012 | ||||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.800 | 1.000 | 2 | 2012 | 2019 | ||||||
Malignant neoplasm of lung
|
1142 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.710 | 1.000 | 2 | 2011 | 2017 | ||||||
Serum HDL cholesterol measurement
|
679 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 2 | 2010 | 2012 | ||||||
Blood basophil count (lab test)
|
452 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma of lung
|
1204 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Chronic Kidney Diseases
|
306 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
Kidney Failure, Chronic
|
425 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||||
Mean Corpuscular Volume (result)
|
549 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||
Phospholipid measurement
|
306 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2008 | 2008 | ||||||
Platelet Count measurement
|
457 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Serum LDL cholesterol measurement
|
555 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||
Serum total cholesterol measurement
|
1243 | 0.851 | 0.160 | 11 | 61803876 | 5 prime UTR variant | C/G;T | snv | 0.700 | 1.000 | 1 | 2012 | 2012 |